Cargando…

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

Detalles Bibliográficos
Autores principales: Kimura, Hideharu, Araya, Tomoyuki, Yoneda, Taro, Shirasaki, Hiroki, Kurokawa, Koji, Sakai, Tamami, Koba, Hayato, Tambo, Yuichi, Nishikawa, Shingo, Sone, Takashi, Kasahara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873691/
https://www.ncbi.nlm.nih.gov/pubmed/31753015
http://dx.doi.org/10.1186/s40880-019-0423-3
_version_ 1783472717177028608
author Kimura, Hideharu
Araya, Tomoyuki
Yoneda, Taro
Shirasaki, Hiroki
Kurokawa, Koji
Sakai, Tamami
Koba, Hayato
Tambo, Yuichi
Nishikawa, Shingo
Sone, Takashi
Kasahara, Kazuo
author_facet Kimura, Hideharu
Araya, Tomoyuki
Yoneda, Taro
Shirasaki, Hiroki
Kurokawa, Koji
Sakai, Tamami
Koba, Hayato
Tambo, Yuichi
Nishikawa, Shingo
Sone, Takashi
Kasahara, Kazuo
author_sort Kimura, Hideharu
collection PubMed
description
format Online
Article
Text
id pubmed-6873691
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68736912019-11-25 Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer Kimura, Hideharu Araya, Tomoyuki Yoneda, Taro Shirasaki, Hiroki Kurokawa, Koji Sakai, Tamami Koba, Hayato Tambo, Yuichi Nishikawa, Shingo Sone, Takashi Kasahara, Kazuo Cancer Commun (Lond) Letter to the Editor BioMed Central 2019-11-21 /pmc/articles/PMC6873691/ /pubmed/31753015 http://dx.doi.org/10.1186/s40880-019-0423-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Kimura, Hideharu
Araya, Tomoyuki
Yoneda, Taro
Shirasaki, Hiroki
Kurokawa, Koji
Sakai, Tamami
Koba, Hayato
Tambo, Yuichi
Nishikawa, Shingo
Sone, Takashi
Kasahara, Kazuo
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
title Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
title_full Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
title_fullStr Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
title_full_unstemmed Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
title_short Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
title_sort long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873691/
https://www.ncbi.nlm.nih.gov/pubmed/31753015
http://dx.doi.org/10.1186/s40880-019-0423-3
work_keys_str_mv AT kimurahideharu longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT arayatomoyuki longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT yonedataro longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT shirasakihiroki longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT kurokawakoji longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT sakaitamami longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT kobahayato longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT tamboyuichi longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT nishikawashingo longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT sonetakashi longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer
AT kasaharakazuo longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer